Latanoprostene bunod

Vyzulta

0.024 % / W/V SolutionCanadaMarketedAuthorised 17 May 2019

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

VyzultaBrazil · BL Indústria Otica LtdaSame brand
Vyzulta (Latanoprostene Bunod Ophthalmic Solution) 0.024%Singapore · 0.24mg/ml · solution, sterile · Bausch & Lomb (Singapore) Private LimitedSame brand
Vyzulta 0.024%, solutionTaiwan · 點眼液劑 · 博士倫股份有限公司Same brand
VyzultaUnited States · 0.024% · solution/drops · Bausch and LombSame brand
Latanoprostene BunodUnited States · 0.024% · solution/drops · GlandSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Latanoprostene bunod

Vyzulta

0.024 % / W/V SolutionCanadaMarketedAuthorised 17 May 2019

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Latanoprostene bunod
Strength: 0.024 % / W/V
Dosage form: Solution
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Marketed
Authorised: 17 May 2019
Registration: DIN 02484218
Marketing authorisation holder: Bausch & Lomb INC
ATC code: S01EE06
Group: Sensory organs
Supply: PRESCRIPTION